Pharma News - Research & Development News & Articles

641 Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation Full Text B3C newswire, February 11, 2013

642 Covidien Announces Continued Relationship with NYSE Euronext Covidien, February 8, 2013

643 Partly Cloudy, Chance of Sunshine Health Data Management, February 8, 2013

644 Cardinal Health Helps Rural Hospitals Elevate Patient Care with Remote Pharmacy Services Full Text Cardinal Health, February 8, 2013

645 Cardinal Health Helps Community Pharmacists Honor Heart Health Month Full Text Cardinal Health, February 8, 2013

646 Novel ACR hybrid score in rheumatoid arthritis applied for the first time to data from the RAPID 1 study with Cimzia (certolizumab pegol) Full Text UCB, February 8, 2013

647 Cimzia (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients Full Text UCB, February 8, 2013

648 UCB to conduct first anti-TNF head-to-head study between Cimzia (certolizumab pegol) and Humira (adalimumab) Full Text UCB, February 8, 2013

649 Baxter, UCB, TRI-VIZOR and H.Essers announce worlds first example of orchestrated carpooling for cargo Full Text UCB, February 8, 2013

650 Anti-Cancer Agent, Herceptin, Filed for Additional Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer By New Drug Application Based on Evidence in the Public Domain Full Text Chugai Pharmaceutical Co., February 8, 2013

651 Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire FR Revascularization Device Full Text Covidien, February 8, 2013

652 New post hoc analyses examined the effects of Neupro (rotigotine) on daytime functioning, daytime symptoms, pain and mood in Restless Legs Syndrome Full Text UCB, February 7, 2013

653 New study finds rheumatoid arthritis (RA) patients preferred ergonomically designed Cimzia (certolizumab pegol) syringe to conventional prefilled syringe Full Text UCB, February 7, 2013

654 New survey finds rheumatoid arthritis patients value personalised goal setting for successful disease management Full Text UCB, February 7, 2013

655 New data for Cimzia (certolizumab pegol) showed a rapid clinical response across a broad population of rheumatoid arthritis (RA) patients Full Text UCB, February 7, 2013

656 Amgen and UCB team up with NASA on final space shuttle mission to conduct preclinical test of sclerostin antibody on bone loss Full Text UCB, February 7, 2013

657 Statement From Sarepta Therapeutics on Stock Volatility Full Text Sarepta Therapeutics, February 7, 2013

658 PhRMA Statement on Clinical Trials and Bad Pharma Full Text PhRMA, February 7, 2013

659 Watson Confirms Opana ER Patent Challenge Full Text Actavis, February 7, 2013

660 Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in Patients with Multiply Relapsed or Refractory Aggressive B-cell NHL Treated with PixuvriTM Who Received Prior Doxorubicin Therapy Full Text Cell Therapeutics, February 7, 2013

1 FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections BioPharm International, April 15, 2013    Free full text

2 New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues Abbott, March 29, 2013    Free full text

3 Dr. Reddys to Relocate North America HQ BioPharm International, April 11, 2013    Free full text

4 Drug Discovery Initiative Launched in Europe BioPharm International, February 12, 2013    Free full text

5 Sarepta Therapeutics Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy Sarepta Therapeutics, April 10, 2013    Free full text

6 CHOP Collaborates With Pfizers Centers For Therapeutic Innovation To Speed Pediatric Research & Development Pfizer, April 4, 2013    Free full text

7 FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool FDA Press Announcements, April 26, 2013    Free full text

8 New research sheds light on NSAID risks American Pharmacists Association News, April 4, 2013    Free full text

9 Mallinckrodt International Finance S.A. Announces Private Offering of Senior Unsecured Notes Covidien, April 10, 2013    Free full text

10 Doctors Agree Small Lifestyle Changes Can Improve Outcomes of Patients with Type 2 Diabetes, National Survey Finds Janssen, March 15, 2013    Free full text

11 ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors ARIAD Pharmaceuticals, April 10, 2013    Free full text

12 Achieving More Effective and Efficient GMP Auditing BioPharm International, April 3, 2013    Free full text

13 FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms FDA What's New: Drugs, March 15, 2013    Free full text

14 The Future of ACOs Remains Cloudy The Hospitalist, April 11, 2013    Free full text

15 Emerging Outsourcing Trends in 2013 BioPharm International, April 3, 2013    Free full text

16 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

17 Catalent Biologics Expands Into ADCs BioPharm International, April 12, 2013    Free full text

18 Revolutionary Autoinjector Pushes the Limits of High Viscosity Drug Delivery B3C newswire, April 19, 2013    Free full text

19 AstraZeneca to Cut 1600 Positions in R&D Reorganization BioPharm International, March 22, 2013    Free full text

20 Valeant Pharmaceuticals Announces Private Exchange Offer Valeant Pharmaceuticals International, April 1, 2013    Free full text